Arnav Srivastava

Aspiring urologic oncologist
SUO Fellow at @UMichUrology by way of @rwjurology and @hopkinsmedicine
Tweets mostly about urology and basketball.

[Todd 〽️ Morgan, MD @wandering_gu]

It was a real pleasure to be involved in the recent @NCIDirector visit to @UMRogelCancer. Grateful Dr. Letai carved away time to hear what we're up to in Ann Arbor, and it was great learning about some current @theNCI priorities related to conduct of clinical trials. #GoBlue

[Arnav Srivastava @4rnav]

@UMichUrology @UrologyHSR

[JAMA Network Open @JAMANetworkOpen]

Less efficient ACOs in the Medicare Shared Savings Program were more likely to earn bonuses than efficient ACOs, with no significant narrowing after the 2017 regional benchmark adjustment.

https://t.co/vMTVycN68v

[Arnav Srivastava @4rnav]

Looking forward to #SUO this year in Phoenix. For any residents and/or upcoming SUO applicants, please reach out if you have any questions about our terrific urologic oncology fellowship at @UMichUrology
@SUO_YUO
@UroOnc

[Steven Monda @monda_steven]

BCG-unresponsive NMIBC trials feel confusing—and inconsistent EFS reporting is a big reason why
We analyze the CIS+ cohorts of 4-FDA registration trials to provide interpretable EFS estimates
🧵👇
@Annals_Oncology

@tompowles1
@JoshMeeks
@wandering_gu

https://t.co/UVlffMc8qY

[Arnav Srivastava @4rnav]

Great work by @Daws_Hill, one of our med students at @UMichUrology
Mentorship by @hollenbeck1971 and @VahaknS

[JAMA Network Open @JAMANetworkOpen]

Black men with newly diagnosed prostate cancer were less likely to receive confirmatory testing, indicating poorer care, but also less likely to be overtreated, according to this cross-sectional study. https://t.co/oWQCQolLIE @4rnav

[JAMA Oncology @JAMAOnc]

Among two U.S prostate cancer registries, the proportion of patients undergoing prostatectomy for indolent cancer dropped over five-fold from 2010 to 2024. https://t.co/h59Cg7GIXN @monda_steven @4rnav @MUSICurology @wandering_gu

[Michigan Urology @UMichUrology]

Welcome, Dr. Jason Qian! We're thrilled to announce our 2026 Society of Urologic Oncology (SUO) Fellow, who will be joining us from his residency at Massachusetts General Brigham. Welcome to Michigan Urology! 💙💛

[Arnav Srivastava @4rnav]

Next cycle fellowship cycle!
Melinda Fu @MelindaFu3 (@SUO_YUO)
Raeesa Islam @IslamRaeesa (@SocietyGURS )

Talented residents, both with high profile podium presentations at #AUA2025

[Arnav Srivastava @4rnav]

Incredibly proud of my former junior residents, Rachel Passarelli @rpassarellimd (@SocietyGURS) and John Pfail @JohnPfail (@SPU_Urology), now applying for fellowships.

Both phenomenal surgeons leading their own science
@rwjurology
#AUA2025

[Steven Monda @monda_steven]

1/
Has there been an improvement in surgical overtreatment of prostate cancer over the past 2 decades?
Yes — and profoundly.
In 2010, 1 in 3 prostatectomies 🔪 were for indolent disease.
In 2024, it's 1 in 20.
Read our work below, presented at #AUA2025 today. 🧵

[Rod Dunn @redunndant]

Wonderful night with old and new friends at the #AUA25 Dow HSR Division Dinner

[Arnav Srivastava @4rnav]

Terrific work on a podium presentation by @Daws_Hill, one of our best medical students at @UMichUrology who will be applying for urology residency soon enough.

A smooth presentation at the intersection of disparities, quality, and utilization in prostate cancer.

[Arnav Srivastava @4rnav]

Many thanks to the @AmerUrological for their support and interest in the work we are doing at @UMichUrology!
As health services researchers, the policy lens of what we do often determines the impact of our work
@BenPockros @CatherineSNamMD

[Amer. Urol. Assn. @AmerUrological]

#AUASummit25 is almost over, but we still have a couple of exciting presentations left, including one starting now with @4rnav. In his presentation, he will discuss aligning payment models and quality in prostate cancer care, including the rationale for new payment models, current payment strategies and disease-specific payment models.

[Arnav Srivastava @4rnav]

@lichtbroun @saumyg Tremendous effort by @lichtbroun as well our mentors at @rwjurology and @OSU_Urology to add literature in a rare disease space

[Arnav Srivastava @4rnav]

As the @SUO_YUO interview season please reach out with any questions about our program or the process in general

Many great programs out there. But if you want to be a surgeon-scientist, there is no place like @UMichUrology

[Michigan Urology @UMichUrology]

🌟 Spotlight on our exceptional SUO Research Fellows!

Their dedication to advancing urologic oncology through groundbreaking research is driving innovation and improving patient outcomes!

[Rutgers RWJ Urology @rwjurology]

Thrilled to announce that our program is expanding from 2–>3 residents/year starting with this upcoming intern class. Thank you to our fearless leaders @TomJangUroOnc and Dr. Barone for their unwavering determination to get this done 🙌

[Arnav Srivastava @4rnav]

Some of our work in alternative payment development and evaluation at @UMichUrology in collaboration with @MUSICUrology

APM development remains very challenging ... but also potentially very promising

@VahaknS
@hollenbeck1971
@UM_IHPI

[JAMA Network Open @JAMANetworkOpen]

A payment incentive was not linked with more active surveillance adoption in men with low-risk prostate cancer vs the preincentive period. https://t.co/uqGW0bVyql @4rnav @MUSICurology

[Arnav Srivastava @4rnav]

For any residents and/or upcoming SUO applicants, please reach out if you have any questions about our terrific urologic oncology fellowship at @UMichUrology or the fellowship process in general
@SUO_YUO
@UroOnc

[ACS Journal Cancer @JournalCancer]

How do commercial prices affect #ProstateCancer care in patients insured by Medicare? New research from @4rnav et al explains more: https://t.co/DCLmZlXjP0 @Oncoalert #PCSM CC: @WalterStadler5